Skip to main content
. 2024 Jul 15;15:1393616. doi: 10.3389/fphar.2024.1393616

TABLE 3.

Statistical tests of additive and multiplicative models.

Drug A Drug B Adverse reaction Additive model (α = 0.05) Multiplicative model (α = 0.05)
δ P exp(δ) P
sacubitril/valsartan atorvastatin rhabdomyolysis 0.0004 0.8903 1.7047 0.2533
myopathy 0.0054 0.3700 1.6449 0.0193
myositis 0.0005 0.7163 5.6604 0.1153
blood creatine phosphokinase increased 0.0005 0.8657 0.7906 0.6087
musculoskeletal discomfort 0.0016 0.6245 1.5950 0.2263
rosuvastatin muscular weakness −0.001 0.7623 1.0625 0.8381
myositis −0.0001 0.9282 3.4998 0.2548
blood creatine phosphokinase increased −0.0002 0.8674 1.1860 0.8667
simvastatin musculoskeletal pain 0.0106 0.0118 4.3445 < 0.0001
myopathy 0.0092 0.0995 1.8660 0.0034
myositis 0.0003 0.8259 4.0056 0.2005
blood creatine phosphokinase increased 0.0013 0.4218 3.9149 0.0616